12/2
12:46 pm
blco
Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
12/2
12:14 pm
blco
Why Bausch + Lomb (BLCO) Stock Is Up Today [Yahoo! Finance]
Low
Report
Why Bausch + Lomb (BLCO) Stock Is Up Today [Yahoo! Finance]
12/1
09:41 am
blco
Bausch + Lomb (BLCO): Is the Current Valuation Overlooked After Recent Share Recovery? [Yahoo! Finance]
Low
Report
Bausch + Lomb (BLCO): Is the Current Valuation Overlooked After Recent Share Recovery? [Yahoo! Finance]
11/18
04:50 pm
blco
Bausch + Lomb to Participate in Citi Global Healthcare Conference [Yahoo! Finance]
Low
Report
Bausch + Lomb to Participate in Citi Global Healthcare Conference [Yahoo! Finance]
11/18
04:30 pm
blco
Bausch + Lomb to Participate in Citi Global Healthcare Conference
Low
Report
Bausch + Lomb to Participate in Citi Global Healthcare Conference
11/18
02:25 am
blco
Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation - Analyst/Investor Day Transcript [Seeking Alpha]
Low
Report
Bausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation - Analyst/Investor Day Transcript [Seeking Alpha]
11/16
04:36 am
blco
Is Bausch + Lomb (NYSE:BLCO) Undervalued? A Fresh Look at Its Current Valuation [Yahoo! Finance]
Medium
Report
Is Bausch + Lomb (NYSE:BLCO) Undervalued? A Fresh Look at Its Current Valuation [Yahoo! Finance]
11/14
10:56 am
blco
Bausch + Lomb (NYSE:BLCO) had its price target raised by analysts at Royal Bank Of Canada from $17.00 to $19.00. They now have an "outperform" rating on the stock.
Low
Report
Bausch + Lomb (NYSE:BLCO) had its price target raised by analysts at Royal Bank Of Canada from $17.00 to $19.00. They now have an "outperform" rating on the stock.
11/14
10:32 am
blco
Bausch + Lomb (NYSE:BLCO) had its price target raised by analysts at Wells Fargo & Company from $16.00 to $17.00. They now have an "equal weight" rating on the stock.
Low
Report
Bausch + Lomb (NYSE:BLCO) had its price target raised by analysts at Wells Fargo & Company from $16.00 to $17.00. They now have an "equal weight" rating on the stock.
11/13
08:06 am
blco
Bausch + Lomb CEO Brent Saunders on growth outlook: Biggest contributor will be in surgical [CNBC]
Medium
Report
Bausch + Lomb CEO Brent Saunders on growth outlook: Biggest contributor will be in surgical [CNBC]
11/13
07:28 am
blco
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day [Yahoo! Finance]
Medium
Report
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day [Yahoo! Finance]
11/13
07:00 am
blco
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day
Medium
Report
Bausch + Lomb to Highlight Company Transformation and Growth Strategy at Investor Day
11/10
07:10 am
blco
Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program [Yahoo! Finance]
Low
Report
Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program [Yahoo! Finance]
11/10
06:59 am
blco
Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program
Low
Report
Bausch + Lomb Reports More Than 690,000 Pounds of Contacts Lens, Lens Care and Eye Care Materials Collected Through ONE By ONE Recycling Program
11/3
04:30 pm
blco
Bausch + Lomb to Hold Investor Day on Nov. 13
Low
Report
Bausch + Lomb to Hold Investor Day on Nov. 13
11/1
01:05 am
blco
10/31
08:43 am
blco
Bausch + Lomb (NYSE:BLCO) was given a new $17.00 price target on by analysts at Barclays PLC.
Low
Report
Bausch + Lomb (NYSE:BLCO) was given a new $17.00 price target on by analysts at Barclays PLC.
10/31
07:19 am
blco
Bausch + Lomb (NYSE:BLCO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
Bausch + Lomb (NYSE:BLCO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
10/30
04:43 pm
blco
Bausch + Lomb (NYSE:BLCO) had its price target raised by analysts at JPMorgan Chase & Co. from $13.00 to $16.00. They now have a "neutral" rating on the stock.
Low
Report
Bausch + Lomb (NYSE:BLCO) had its price target raised by analysts at JPMorgan Chase & Co. from $13.00 to $16.00. They now have a "neutral" rating on the stock.
10/30
12:41 pm
blco
Bausch + Lomb (NYSE:BLCO) had its price target raised by analysts at Evercore ISI from $17.00 to $18.00. They now have an "outperform" rating on the stock.
Low
Report
Bausch + Lomb (NYSE:BLCO) had its price target raised by analysts at Evercore ISI from $17.00 to $18.00. They now have an "outperform" rating on the stock.
10/30
10:40 am
blco
Bausch + Lomb (NYSE:BLCO) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc.. They now have a $19.00 price target on the stock, up previously from $18.00.
Low
Report
Bausch + Lomb (NYSE:BLCO) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc.. They now have a $19.00 price target on the stock, up previously from $18.00.
10/30
10:06 am
blco
Bausch + Lomb (NYSE:BLCO) was given a new $16.00 price target on by analysts at Wells Fargo & Company.
Low
Report
Bausch + Lomb (NYSE:BLCO) was given a new $16.00 price target on by analysts at Wells Fargo & Company.
10/29
06:58 am
blco
Bausch + Lomb Announces Third-Quarter 2025 Results
Medium
Report
Bausch + Lomb Announces Third-Quarter 2025 Results
10/11
08:20 pm
blco
Bausch + Lomb (NYSE:BLCO): Evaluating Valuation After Recent Earnings and Share Price Moves [Yahoo! Finance]
Medium
Report
Bausch + Lomb (NYSE:BLCO): Evaluating Valuation After Recent Earnings and Share Price Moves [Yahoo! Finance]
10/8
12:15 pm
blco
Bausch + Lomb (NYSE:BLCO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Neutral
Report
Bausch + Lomb (NYSE:BLCO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.